Purchase Order 75N95B19P00064

<p>The National Institute of Mental Health awarded a purchase order to 10X Genomics, Inc. for $22,241.00 on April 24, 2019. Performance occurs at the awardee's facility in Pleasanton, California. The order is firm fixed price with no small business set-aside. Ultimate completion is April 24, 2019.</p>

<p>The National Institute of Mental Health awarded a purchase order to 10X Genomics, Inc. for laboratory supplies and equipment valued at $12,531.00 on August 13, 2019, with performance at the vendor's Pleasanton, California location. Work was completed by the same date under firm fixed price, commercial item terms with no set-aside applied.</p>

<p>The National Institute of Mental Health awarded a purchase order to 10X Genomics, Inc. valued at $24,258.00 on July 19, 2019. Performance occurred in Pleasanton, California. The order was firm fixed price with no small business set-aside. Ultimate completion was July 19, 2019. No solicitation number is referenced in the source. No Service Contract Inventory data is provided.</p>

<p>The National Institute of Mental Health awarded a purchase order to 10X Genomics, Inc. for $12,886.20 on June 23, 2021. Work is performed in Pleasanton, California. The order carries no small business set-aside. The ultimate completion date is June 23, 2021.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc. valued at $22,606.67 on June 9, 2025, with completion scheduled for January 31, 2026. Place of performance is Pleasanton, California. The call is firm fixed price with no set-aside. Specific deliverables are not detailed in the source material.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc., with a ceiling value of $24,316.17 and an award date of July 22, 2025. Performance is scheduled to conclude by July 21, 2026, and will be delivered from Pleasanton, California. The call carries no set-aside designation and is priced on a firm fixed price basis. Specific deliverables and detailed scope are not described in the source.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc., with a ceiling value of $21,905.30 and an award date of April 13, 2022. The call is firm fixed price with an ultimate completion date of January 31, 2025. Place of performance is Pleasanton, California. No set-aside was used.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc., with a ceiling value of $24,309.00, awarded April 13, 2022. The ultimate completion date is January 31, 2026. Place of performance is Pleasanton, California. The call is firm fixed price with no set-aside applied. Specific scope details regarding the genomic analysis instruments, consumables, or reagent deliverables are not stated in the available source material.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc., valued at $24,330.17, on July 16, 2025. The call carries a firm fixed price and an ultimate completion date of January 31, 2026. Place of performance is Pleasanton, California. No set-aside was used. The specific requirements and deliverables are not detailed in the award record.</p>

<p>The National Institute of Mental Health issued a BPA call to 10X Genomics, Inc. valued at $24,906.17 on June 5, 2025, with an ultimate completion date of January 31, 2026. Place of performance is Pleasanton, California. The call carries no set-aside and is priced firm fixed price. Specific delivery requirements are not detailed in the award documentation.</p>